0	1	{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(0, 0), 'end':(0, 19), 'text':'Expression of p53 , inducible nitric oxide synthase and vascular endothelial growth factor in gastric precancerous and cancerous lesions :'}, {'start':(0, 20), 'end':(0, 23), 'text':'correlation with clinical features'}]}
18	39	{'label':'contrast', 'direction':'None', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(0, 0), 'end':(0, 15), 'text':'Gastric adenocarcinoma ( GC ) is one of the most common malignant diseases in China .'}, {'label':'contrast', 'direction':'RightToLeft', 'children':[{'start':(1, 0), 'end':(1, 10), 'text':'Although the GC has been declined in its mortality rate ,'}, {'start':(1, 11), 'end':(1, 41), 'text':'it remains the leading cause of cancer related deaths in this country ( Parkin et al. , 1992 ; World Health Organization , 1994 ; Nomura A , 1996 ) .'}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(2, 0), 'end':(2, 9), 'text':'Gastric carcinogenesis is considered as a multistage progressive process .'}, {'label':'contrast', 'direction':'None', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(3, 0), 'end':(3, 29), 'text':'The early indicator for the subject predisposed to GC is abnormal hyperproliferation of gastric epithelial cells , such as chronic atrophic gastritis ( CAG ) , DYS and intestinal metaplasia'}, {'start':(3, 30), 'end':(3, 33), 'text':'( IM ) ,'}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(3, 34), 'end':(3, 42), 'text':'which have been considered as precancerous lesions of GC'}, {'start':(3, 43), 'end':(3, 55), 'text':'( You et al. , 1993 ; Correa P , 1992 ) .'}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(4, 0), 'end':(4, 13), 'text':'However , the information for the mechanism of gastric carcinogenesis is very limited .'}, {'label':'joint', 'direction':'None', 'children':[{'start':(5, 0), 'end':(5, 17), 'text':'The growth and metastasis of tumors depend on the development of an adequate blood supply via angiogenesis .'}, {'label':'joint', 'direction':'None', 'children':[{'label':'attribution', 'direction':'RightToLeft', 'children':[{'start':(6, 0), 'end':(6, 2), 'text':'Recent studies indicate'}, {'label':'same-unit', 'direction':'None', 'children':[{'start':(6, 3), 'end':(6, 16), 'text':'that the inducible nitric oxide synthase ( iNOS ) , vascular endothelial growth factor'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(6, 17), 'end':(6, 30), 'text':'( VEGF ) and tumor suppressor p53 are fundamental play-makers of the angiogenic process'}, {'start':(6, 31), 'end':(6, 56), 'text':'( Ambs et al. , 1994 ; Jekins et al. , 1995 ; Forrester et al. , 1996 ; Chiarugi et al. , 1998 ) .'}]}]}]}, {'label':'joint', 'direction':'None', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(7, 0), 'end':(7, 9), 'text':'iNOS is one of the isoforms of nitric oxide synthase'}, {'start':(7, 10), 'end':(7, 23), 'text':'that catalyzes the formation of nitric oxide , a regulator of vascular permeability .'}]}, {'label':'joint', 'direction':'None', 'children':[{'start':(8, 0), 'end':(8, 4), 'text':'VEGF is a dimeric glycoprotein'}, {'start':(8, 5), 'end':(8, 13), 'text':'and has specific mitogenic activity for endothelial cells .'}]}]}]}]}]}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(9, 0), 'end':(9, 10), 'text':'Over-expression of iNOS and VEGF could induce angiogenesis in tumors .'}, {'label':'manner-means', 'direction':'LeftToRight', 'children':[{'start':(10, 0), 'end':(10, 2), 'text':'P53 suppresses angiogenesis'}, {'start':(10, 3), 'end':(10, 9), 'text':'by down regulating VEGF and iNOS .'}]}]}]}]}, {'label':'contrast', 'direction':'RightToLeft', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(11, 0), 'end':(11, 9), 'text':'Mutant p53 potentiates protein kinase C induction of VEGF expression'}, {'start':(11, 10), 'end':(11, 17), 'text':'( Zhang et al. , 2000 ) .'}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'same-unit', 'direction':'None', 'children':[{'start':(12, 0), 'end':(12, 8), 'text':'In a tumorigenicity model using human fibroblast cells ,'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(12, 9), 'end':(12, 23), 'text':'the loss of wild-type p53 and transfection of activated ras led to increased VEGF expression'}, {'start':(12, 24), 'end':(12, 31), 'text':'( Devavrata et al. , 1995 ) .'}]}]}, {'label':'joint', 'direction':'None', 'children':[{'start':(13, 0), 'end':(13, 23), 'text':'Transient transfection of wild-type p53 and of v-src has been found to exert opposing effects on human VEGF gene promoter activity in human glioblastoma'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(13, 24), 'end':(13, 29), 'text':'and transformed human fetal kidney cells'}, {'start':(13, 30), 'end':(13, 36), 'text':'( Devavrata et al. ,1995 ) .'}]}]}]}]}, {'label':'same-unit', 'direction':'None', 'children':[{'start':(14, 0), 'end':(14, 1), 'text':'However ,'}, {'label':'contrast', 'direction':'RightToLeft', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(14, 2), 'end':(14, 14), 'text':'because wild-type p53 did not repress hypoxia induced transcription of the VEGF gene'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(14, 15), 'end':(14, 32), 'text':'in stably transfected human colorectal carcinoma and human hepatoblastoma cells with an inducible p53-estrogen-receptor fusion protein expression system'}, {'start':(14, 33), 'end':(14, 40), 'text':'( Ambs et al. , 1998 ) ,'}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(14, 41), 'end':(14, 44), 'text':'it has been proposed'}, {'start':(14, 45), 'end':(14, 65), 'text':'that there is a need for caution in interpreting p53 function on the basis of cells transiently overexpressing this protein .'}]}]}]}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'same-unit', 'direction':'None', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(15, 0), 'end':(15, 25), 'text':'Nevertheless , mutant p53 has been correlated with increased VEGF expression in human lung cancer ( Ambs et al. , 1994 ) , and colorectal cancer'}, {'start':(15, 26), 'end':(15, 31), 'text':'( Ambs et al. ,1999 )'}]}, {'start':(15, 32), 'end':(15, 38), 'text':'by immunohistochemical staining of surgical specimens .'}]}, {'label':'joint', 'direction':'None', 'children':[{'label':'attribution', 'direction':'RightToLeft', 'children':[{'start':(16, 0), 'end':(16, 3), 'text':'It has been reported'}, {'start':(16, 4), 'end':(16, 22), 'text':'that dysfunction of the p53 and MDM -2 pathway can be found in more than two-thirds of angiosarcomas ;'}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(16, 23), 'end':(16, 45), 'text':'thus , mutant p53 influences the development of angiosarcoma not only by affecting growth and apoptosis control but also by up regulating VEGF'}, {'start':(16, 46), 'end':(16, 53), 'text':'( Chinrugi et al. , 1998 ) .'}]}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'attribution', 'direction':'RightToLeft', 'children':[{'start':(17, 0), 'end':(17, 1), 'text':'We hypothesized'}, {'label':'joint', 'direction':'None', 'children':[{'start':(17, 2), 'end':(17, 15), 'text':'that alterations of p53 , iNOS and VEGF expression may contribute to gastric carcinogenesis'}, {'start':(17, 16), 'end':(17, 25), 'text':'and influence the clinical behavior of GC via angiogenesis .'}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(18, 0), 'end':(18, 24), 'text':'The correlation of expression of p53 , VEGF and iNOS and clinical features in gastric carcinogenesis , however , has not been well characterized .'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'enablement', 'direction':'RightToLeft', 'children':[{'start':(19, 0), 'end':(19, 15), 'text':'To characterize the changes of p53 , iNOS and VEGF expression in human gastric carcinogenesis ,'}, {'start':(19, 16), 'end':(19, 70), 'text':'the present study was undertaken to determine the protein level of p53 , iNOS and VEGF in normal tissues and the tissues with different severities of lesions of CSG , CAG , DYS , IM and GC with and without lymph node metastasis from surgically resected human GC and gastric biopsies from symptom-free subjects .'}]}, {'start':(20, 0), 'end':(20, 21), 'text':'The subjects were from Linzhou and nearby county Huixian in Henan province , the high-incidence area for GC in northern China .'}]}]}]}]}]}
125	127	{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(0, 0), 'end':(0, 1), 'text':'Pre-publication history'}, {'start':(1, 0), 'end':(1, 10), 'text':'The pre-publication history for this paper can be accessed here :'}]}
1	18	{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'attribution', 'direction':'RightToLeft', 'children':[{'start':(0, 0), 'end':(0, 0), 'text':'Background'}, {'start':(1, 0), 'end':(1, 17), 'text':'The growth and metastasis of tumors depend on the development of an adequate blood supply via angiogenesis .'}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'attribution', 'direction':'RightToLeft', 'children':[{'start':(2, 0), 'end':(2, 2), 'text':'Recent studies indicate'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(2, 3), 'end':(2, 16), 'text':'that the inducible nitric oxide synthase ( iNOS ) , vascular endothelial growth factor'}, {'start':(2, 17), 'end':(2, 32), 'text':'( VEGF ) and the tumor suppressor p53 are fundamental play-markers of the angiogenic process .'}]}]}, {'start':(3, 0), 'end':(3, 13), 'text':'Overexpression of iNOS and VEGF has been shown to induce angiogenesis in tumors .'}]}]}, {'label':'manner-means', 'direction':'LeftToRight', 'children':[{'start':(4, 0), 'end':(4, 2), 'text':'P53 suppresses angiogenesis'}, {'start':(4, 3), 'end':(4, 9), 'text':'by down regulating VEGF and iNOS .'}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(5, 0), 'end':(5, 24), 'text':'The correlation of expression of p53 , VEGF and iNOS and clinical features in gastric carcinogenesis , however , has not been well characterized .'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'attribution', 'direction':'RightToLeft', 'children':[{'start':(6, 0), 'end':(6, 0), 'text':'Methods'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(7, 0), 'end':(7, 55), 'text':'The expression of p53 , iNOS and VEGF in gastric precancerous and cancerous lesions and its relation with the clinical features was determined with immunohistochemistry ( avidin-biotin-peroxidase complex method ) on 55 randomly selected GC patients and 60 symptom-free subjects from the mass survey in the high-incidence area for GC in Henan , northern China .'}, {'label':'attribution', 'direction':'RightToLeft', 'children':[{'start':(8, 0), 'end':(8, 0), 'text':'Results'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'contrast', 'direction':'None', 'children':[{'label':'joint', 'direction':'None', 'children':[{'start':(9, 0), 'end':(9, 24), 'text':'The positive immunostainig rates for p53 , iNOS and VEGF in gastric carcinomas were 51 % , 44 % and 51 % , respectively ,'}, {'start':(9, 25), 'end':(9, 31), 'text':'and correlated well with TNM stages ,'}]}, {'start':(9, 32), 'end':(9, 51), 'text':'but did not show significant difference among the groups with different degrees of gastric wall invasion depth by GC .'}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(10, 0), 'end':(10, 14), 'text':'A positive immunostaining reaction for the iNOS protein was significantly correlated with lymph node metastasis'}, {'start':(10, 15), 'end':(10, 24), 'text':'( p = 0.019 ; Spearman correlation coefficient ) .'}]}]}]}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(11, 0), 'end':(11, 6), 'text':'P53 protein accumulation was higher in the'}, {'start':(11, 7), 'end':(11, 16), 'text':'poorly differentiated gastric carcinoma than in well differentiated one .'}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'contrast', 'direction':'None', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(12, 0), 'end':(12, 23), 'text':'In gastric biopsies , no positive immunosatining was observed for p53 , iNOS and VEGF in the histologically normal tissue and chronic superficial gastritis'}, {'start':(12, 24), 'end':(12, 27), 'text':'( CSG ) .'}]}, {'label':'joint', 'direction':'None', 'children':[{'start':(13, 0), 'end':(13, 37), 'text':'However , p53 , iNOS and VEGF positive immunostaining was observed in the tissues with different severities of lesions of chronic atrophic gastritis ( CAG ) , intestinal metaplasia ( IM ) and dysplasia ( DYS ) ,'}, {'start':(13, 38), 'end':(13, 53), 'text':'and the positive rates increased with the lesion progression from CAG to IM to DYS .'}]}]}, {'start':(14, 0), 'end':(14, 39), 'text':'A high coincidental positive and negative immunostaining rate for p53 , iNOS and VEGF was observed both in biopsy samples with CAG , IM and DYS from the symptom-free subjects and in gastric cancer tissue from the GC patients .'}]}]}]}]}, {'label':'attribution', 'direction':'RightToLeft', 'children':[{'start':(15, 0), 'end':(15, 0), 'text':'Conclusions'}, {'label':'attribution', 'direction':'RightToLeft', 'children':[{'start':(16, 0), 'end':(16, 3), 'text':'The present results indicated'}, {'start':(16, 4), 'end':(16, 27), 'text':'that p53 protein accumulation and increased expression of iNOS and VEGF might be responsible for gastric carcinogenesis and tumor aggressiveness of gastric cancer .'}]}]}]}]}
102	123	{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'attribution', 'direction':'RightToLeft', 'children':[{'start':(0, 0), 'end':(0, 0), 'text':'Discussion'}, {'label':'attribution', 'direction':'RightToLeft', 'children':[{'start':(1, 0), 'end':(1, 6), 'text':'An interesting observation in this study was'}, {'start':(1, 7), 'end':(1, 24), 'text':'that the immunoreactivity of p53 , iNOS and VEGF occurred in the early stage of gastric carcinogenesis .'}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(2, 0), 'end':(2, 11), 'text':'The positive immunostaining cells were invariably associated with cell proliferate activity .'}, {'start':(3, 0), 'end':(3, 49), 'text':'With the lesions progressed from normal to CSG to CAG to IM to DYS , and to GC , the positive immunostaining rates for p53 , iNOS and VEGF increased significantly , the increasing tendency for p53 , iNOS and VEGF had a good linear correlation with lesions progression .'}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'attribution', 'direction':'RightToLeft', 'children':[{'start':(4, 0), 'end':(4, 3), 'text':'The present results indicated'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(4, 4), 'end':(4, 19), 'text':'that p53 protein accumulation and increased expression of iNOS and VEGF may be important molecular events'}, {'start':(4, 20), 'end':(4, 28), 'text':'involved in the early stage of gastric carcinogenesis .'}]}]}, {'label':'attribution', 'direction':'RightToLeft', 'children':[{'start':(5, 0), 'end':(5, 3), 'text':'Another interesting observation was'}, {'start':(5, 4), 'end':(5, 30), 'text':'that , a high coincidental positive immunostaining rates for p53 and iNOS ( 36 % ) and p53 and VEGF ( 35 % ) was observed .'}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(6, 0), 'end':(6, 12), 'text':'This result was consistent with the findings in human lung and colon carcinomas'}, {'start':(6, 13), 'end':(6, 20), 'text':'( Ambs et al. , 1999 ) .'}]}, {'label':'contrast', 'direction':'RightToLeft', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(7, 0), 'end':(7, 2), 'text':'Although p53 antibody'}, {'start':(7, 3), 'end':(7, 15), 'text':'used in this study could not differentiate wild-type p53 from mutant p53 ,'}]}, {'label':'attribution', 'direction':'RightToLeft', 'children':[{'start':(7, 16), 'end':(7, 19), 'text':'previous studies have indicated'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(7, 20), 'end':(7, 22), 'text':'that p53 protein'}, {'start':(7, 23), 'end':(7, 32), 'text':'detected by immunohistochemistry seems to representative most mutant p53 .'}]}]}]}]}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(8, 0), 'end':(8, 14), 'text':'Accumulation of p53 is an indicator for a loss of p53 tumor suppressor function .'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(9, 0), 'end':(9, 10), 'text':'Both mutations and protein protein interactions can cause a p53 accumulation'}, {'start':(9, 11), 'end':(9, 19), 'text':'( Wang , et al. , 1994 ) .'}]}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'background', 'direction':'RightToLeft', 'children':[{'start':(10, 0), 'end':(10, 20), 'text':'Considering that p53 protein accumulation was correlated with poorly differentiation and T2 , T3 and T4 TNM stage of GC ,'}, {'label':'attribution', 'direction':'RightToLeft', 'children':[{'start':(10, 21), 'end':(10, 22), 'text':'we concluded'}, {'label':'cause', 'direction':'LeftToRight', 'children':[{'start':(10, 23), 'end':(10, 45), 'text':'that p53 protein accumulation in this study may lead to the loss of cell proliferation control and inhibition for iNOS and VEGF ,'}, {'start':(10, 46), 'end':(10, 52), 'text':'possibly because of p53 gene mutation .'}]}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(11, 0), 'end':(11, 17), 'text':'Thus , the high coincidental expression of iNOS and VEGF and p53 protein accumulation may be important events'}, {'label':'joint', 'direction':'None', 'children':[{'start':(11, 18), 'end':(11, 25), 'text':'to enhance gastric carcinogenesis and poorly clinical features'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(11, 26), 'end':(11, 30), 'text':'and may be useful biomarkers'}, {'start':(11, 31), 'end':(11, 39), 'text':'to assess risk for the development of GC .'}]}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'attribution', 'direction':'RightToLeft', 'children':[{'start':(12, 0), 'end':(12, 7), 'text':'Recent studies on Japanese GC patients have showed'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(12, 8), 'end':(12, 21), 'text':'that increased expression of VEGF and p53 protein accumulation are associated with intra-tumoral angiogenesis'}, {'start':(12, 22), 'end':(12, 62), 'text':'( Takeuchi , et al. , 2000 ; Saito , et al. , 1999 ) and poor prognosis ( Skatani , et al. , 2000 ; Ikeguchi , et al. , 2000 ; Maeda , et al. , 1998 ) .'}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'attribution', 'direction':'RightToLeft', 'children':[{'start':(13, 0), 'end':(13, 1), 'text':'Rajnkova reported'}, {'label':'manner-means', 'direction':'LeftToRight', 'children':[{'start':(13, 2), 'end':(13, 11), 'text':'that increased expression of iNOS may promote gastric cancer progression'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(13, 12), 'end':(13, 22), 'text':'by providing a selective growth advantage to tumor cells with non'}, {'start':(13, 23), 'end':(13, 25), 'text':'functioning p53 .'}]}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(14, 0), 'end':(14, 7), 'text':'( Rajnkova , et al. , 2001 )'}, {'label':'attribution', 'direction':'RightToLeft', 'children':[{'start':(15, 0), 'end':(15, 6), 'text':'The third observation in this study was'}, {'start':(15, 7), 'end':(15, 29), 'text':'that increased expression of iNOS and VEGF and p53 protein accumulation occurred with a high frequency in gastric biopsy samples with IM .'}]}]}]}]}]}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'same-unit', 'direction':'None', 'children':[{'start':(16, 0), 'end':(16, 1), 'text':'IM ,'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(16, 2), 'end':(16, 13), 'text':'which may be defined as the replacement of gastric mucosa by glands'}, {'start':(16, 14), 'end':(16, 36), 'text':'which have the histological , histochemical , and physiological characteristics of the small intestine , has been strongly associated with stomach cancer .'}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'joint', 'direction':'None', 'children':[{'label':'attribution', 'direction':'RightToLeft', 'children':[{'start':(17, 0), 'end':(17, 3), 'text':'The present results demonstrated'}, {'start':(17, 4), 'end':(17, 14), 'text':'that IM was a unstable stage with active molecular changes ,'}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(17, 15), 'end':(17, 17), 'text':'and further analysis'}, {'start':(17, 18), 'end':(17, 38), 'text':'to compare these changes with normal small intestine will provides more information for the significance of IM in gastric carcinogenesis .'}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'same-unit', 'direction':'None', 'children':[{'label':'attribution', 'direction':'RightToLeft', 'children':[{'start':(18, 0), 'end':(18, 5), 'text':'Finally , the present study demonstrated'}, {'start':(18, 6), 'end':(18, 21), 'text':'that the positive immunostaining rates of iNOS was correlated well with GC lymph node metastasis ,'}]}, {'start':(18, 22), 'end':(18, 38), 'text':'increased expression of VEGF and p53 protein accumulation was related with TNM stages and GC differentiation .'}]}, {'label':'attribution', 'direction':'RightToLeft', 'children':[{'start':(19, 0), 'end':(19, 2), 'text':'These findings indicate'}, {'start':(19, 3), 'end':(19, 16), 'text':'that p53 , iNOS and VEGF may be useful biomarkers for GC aggressiveness .'}]}]}]}]}, {'start':(20, 0), 'end':(20, 38), 'text':'The molecular basis for the observed expression of iNOS and VEGF and p53 protein accumulation and their roles in the progression of gastric pre-cancerous lesions and angeogenesis requires to be carefully investigated in the laboratory and follow-up studies .'}]}]}
78	102	{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'attribution', 'direction':'RightToLeft', 'children':[{'start':(0, 0), 'end':(0, 0), 'text':'Results'}, {'start':(1, 0), 'end':(1, 13), 'text':'Histopathologically , all the 55 surgically resected gastric specimens were confirmed as adenocarcinoma .'}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(2, 0), 'end':(2, 18), 'text':'Of the 55 GC patients , 11 cases occurred the invasion within sub-mucosa , 44 with whole-muscle layer .'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(3, 0), 'end':(3, 30), 'text':'Of the 60 biopsy-samples examined , 10 were diagnosed as normal , 15 as CSG , 9 as CAG , 16 as IM with CAG , and 10 as DYS .'}, {'label':'contrast', 'direction':'None', 'children':[{'start':(4, 0), 'end':(4, 33), 'text':'The positive immunostaining for p53 , iNOS and VEGF was observed in the gastric epithelial cells and cancer cells with different rates in the lesions of CAG , DYS , IM and GC .'}, {'start':(5, 0), 'end':(5, 21), 'text':'But , the positive immunostaining for p53 , iNOS and VEGF was not observed in normal gastric epithelial tissue and CSG .'}]}]}, {'start':(6, 0), 'end':(6, 15), 'text':'Figure , and shows the representative of p53 , iNOS and VEGF immunostaining in GC .'}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(7, 0), 'end':(7, 21), 'text':'p53 immunoreactivity was located in the nuclei , VEGF and iNOS immunoreactivity were located mainly in the cytoplasm and cell membrane .'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'joint', 'direction':'None', 'children':[{'start':(8, 0), 'end':(8, 21), 'text':'iNOS immunostaining was confirmed by Western Blot on part of iNOS positive and negative slides ( three slides for each ) ,'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(8, 22), 'end':(8, 34), 'text':'and consistent results were obtained for iNOS immunohistochemistry and Western Blot ( data'}, {'start':(8, 35), 'end':(8, 38), 'text':'not shown ) .'}]}]}, {'label':'joint', 'direction':'None', 'children':[{'start':(9, 0), 'end':(9, 11), 'text':'The positive immunostaining rate for p53 was very low in CAG ,'}, {'label':'joint', 'direction':'None', 'children':[{'start':(9, 12), 'end':(9, 19), 'text':'and slightly increased in IM and DYS ,'}, {'start':(9, 20), 'end':(9, 25), 'text':'and significantly increased in GC .'}]}]}]}]}]}, {'start':(10, 0), 'end':(10, 8), 'text':'Similar results were observed in iNOS and VEGF .'}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(11, 0), 'end':(11, 15), 'text':'P53 positive immunosatining rate in well differentiated GC was lower than that in poorly differentiated GC'}, {'start':(11, 16), 'end':(11, 23), 'text':'( p = 0.012 , Table ) .'}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(12, 0), 'end':(12, 13), 'text':'iNOS positive staining was similar among the GC with different degree of differentiation .'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'contrast', 'direction':'RightToLeft', 'children':[{'start':(13, 0), 'end':(13, 15), 'text':'Although VEGF immunostaining rate in poorly differentiated GC was higher than in well differentiated GC ,'}, {'start':(13, 16), 'end':(13, 21), 'text':'the difference was not significant .'}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'contrast', 'direction':'None', 'children':[{'label':'same-unit', 'direction':'None', 'children':[{'start':(14, 0), 'end':(14, 16), 'text':'iNOS positive immunostaining rate in the cases with deep invasion of GC ( through muscle layers )'}, {'start':(14, 17), 'end':(14, 29), 'text':'was higher than in those with superficial invasion ( within submucosa ) ,'}]}, {'start':(14, 30), 'end':(14, 37), 'text':'but , the difference was not significant .'}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(15, 0), 'end':(15, 14), 'text':'P53 and VEGF immunostaining was similar in GC patients with superficial and deep invasion .'}, {'label':'contrast', 'direction':'RightToLeft', 'children':[{'label':'manner-means', 'direction':'LeftToRight', 'children':[{'start':(16, 0), 'end':(16, 15), 'text':'iNOS immunosatining rate in the cases with lymph node metastasis was higher than that in those'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(16, 16), 'end':(16, 19), 'text':'without lymph node metastasis'}, {'start':(16, 20), 'end':(16, 27), 'text':'( p = 0.014 , Table ) .'}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(17, 0), 'end':(17, 5), 'text':'However , there was no difference'}, {'start':(17, 6), 'end':(17, 20), 'text':'observed for p53 and VEGF between the cases with and without lymph node metastasis .'}]}]}]}]}]}]}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(18, 0), 'end':(18, 26), 'text':'P53 immunostaining rate in the cases with TNM grade T1 was lower than that in those with TNM grade T2 , T3 and T4 ( T1 :'}, {'label':'joint', 'direction':'None', 'children':[{'start':(18, 27), 'end':(18, 32), 'text':'T3 , p = 0.023 ;'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(18, 33), 'end':(18, 34), 'text':'T1 :'}, {'start':(18, 35), 'end':(18, 41), 'text':'T4 , p = 0.012 ) .'}]}]}]}, {'label':'contrast', 'direction':'None', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(19, 0), 'end':(19, 5), 'text':'Similar results were observed in VEGF'}, {'start':(19, 6), 'end':(19, 8), 'text':'( T1 :'}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(19, 9), 'end':(19, 12), 'text':'T2 and T2 :'}, {'label':'joint', 'direction':'None', 'children':[{'start':(19, 13), 'end':(19, 18), 'text':'T3 , p = 0.015 ;'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(19, 19), 'end':(19, 20), 'text':'T1 :'}, {'label':'joint', 'direction':'None', 'children':[{'start':(19, 21), 'end':(19, 26), 'text':'T4 , p = 0.014 ;'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(19, 27), 'end':(19, 28), 'text':'T2 :'}, {'start':(19, 29), 'end':(19, 37), 'text':'T4 , p = 0.01 , Table ) .'}]}]}]}]}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(20, 0), 'end':(20, 16), 'text':'However , there was no difference for iNOS immunostaining between the cases with different TNM stages .'}, {'start':(21, 0), 'end':(21, 14), 'text':'A higher coincidental expression of p53 , iNOS and VEGF in GC was observed .'}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(22, 0), 'end':(22, 9), 'text':'Of the 55 cases examined , there were 20 cases'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(22, 10), 'end':(22, 24), 'text':'showing positive staining both for p53 and iNOS ( 36 % ) , 23 cases'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(22, 25), 'end':(22, 36), 'text':'showing negative staining for both p53 and iNOS ( 42 % )'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(22, 37), 'end':(22, 72), 'text':'( p = 0.005 , Table ) , 19 cases showing positive staining both for p53 and VEGF ( 35 % ) and 18 cases showing negative for both p53 and VEGF ( 33 % )'}, {'start':(22, 73), 'end':(22, 80), 'text':'( p = 0.01 , Table ) .'}]}]}]}]}, {'start':(23, 0), 'end':(23, 4), 'text':'The correlations were significant .'}]}]}]}]}]}]}
39	78	{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(0, 0), 'end':(0, 2), 'text':'Materials and Methods'}, {'label':'attribution', 'direction':'RightToLeft', 'children':[{'start':(1, 0), 'end':(1, 0), 'text':'Patients'}, {'label':'joint', 'direction':'None', 'children':[{'start':(2, 0), 'end':(2, 8), 'text':'The present investigation included 55 randomly selected GC patients'}, {'start':(2, 9), 'end':(2, 23), 'text':'and 60 symptom-free subjects from the mass survey in the high-incidence area for GC .'}]}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(3, 0), 'end':(3, 13), 'text':'Fifty-five GC patients were performed gastric cancer surgery at the Linzhou People \'s Hospital'}, {'start':(3, 14), 'end':(3, 27), 'text':'( n = 26 ) and The Second Affiliated Hospital of Henan Medical University'}]}, {'start':(3, 28), 'end':(3, 37), 'text':'( n = 29 ) from 1996 to 1998 .'}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(4, 0), 'end':(4, 15), 'text':'Before surgery , none of the patients received any kinds of chemical or radiation therapy .'}, {'label':'joint', 'direction':'None', 'children':[{'start':(5, 0), 'end':(5, 15), 'text':'The median age of the patients was 61 years ( 30 ~ 77 years ) .'}, {'label':'joint', 'direction':'None', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(6, 0), 'end':(6, 3), 'text':'Cancer specimens were classified'}, {'start':(6, 4), 'end':(6, 44), 'text':'based on TNM as stage T1 ( 19 patients , 35 % ) , T2 ( 14 patients , 25 % ) , T3 ( 12 patients , 22 % ) and T4 ( 10 patients , 18 % ) .'}]}, {'label':'joint', 'direction':'None', 'children':[{'start':(7, 0), 'end':(7, 15), 'text':'The tumors were histologically graded as well differentiated ( 15 patients , 27 % ) ,'}, {'label':'joint', 'direction':'None', 'children':[{'start':(7, 16), 'end':(7, 24), 'text':'moderate differentiated ( 14 patients , 25 % )'}, {'start':(7, 25), 'end':(7, 35), 'text':'and poorly differentiated ( 26 patients , 47 % ) .'}]}]}]}]}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(8, 0), 'end':(8, 15), 'text':'Of the 55 patients , 35 occurred local lymph node metastasis ( 64 % ) .'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(9, 0), 'end':(9, 7), 'text':'Gastric biopsies were taken from 60 symptom-free subjects'}, {'start':(9, 8), 'end':(9, 26), 'text':'who volunteered to participate in a routine endoscopic screening for esophageal and gastric cancer in Huixian , China .'}]}, {'start':(10, 0), 'end':(10, 5), 'text':'No selection process was involved .'}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(11, 0), 'end':(11, 13), 'text':'Of the 60 subjects examined , there were 35 males and 25 females .'}, {'start':(12, 0), 'end':(12, 15), 'text':'The median age of the subjects was 59 years ( 28 ~ 70 years ) .'}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(13, 0), 'end':(13, 14), 'text':'The biopsies were taken each from the pylorus of the stomach from each subject .'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(14, 0), 'end':(14, 1), 'text':'Tissue processing'}, {'label':'joint', 'direction':'None', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(15, 0), 'end':(15, 15), 'text':'All the surgically resected specimens and biopsy samples were fixed with 10 % neutral formalin ,'}, {'start':(15, 16), 'end':(15, 19), 'text':'embedded with paraffin ,'}]}, {'start':(15, 20), 'end':(15, 26), 'text':'and serially sectioned at 5 mum .'}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(16, 0), 'end':(16, 9), 'text':'The sections were mounted onto the histostick coated slides .'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'same-unit', 'direction':'None', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(17, 0), 'end':(17, 9), 'text':'Four or five adjacent ribbons were collected for histopathological analysis'}, {'start':(17, 10), 'end':(17, 15), 'text':'( hematoxylin and eosin stain )'}]}, {'start':(17, 16), 'end':(17, 20), 'text':'and for immunohistochemical staining .'}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(18, 0), 'end':(18, 1), 'text':'Histopathological Analysis'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(19, 0), 'end':(19, 14), 'text':'Histopathological diagnosis for gastric epithelia was made according to cellular morphological changes and tissue architecture'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(19, 15), 'end':(19, 18), 'text':'using previously established criteria'}, {'start':(19, 19), 'end':(19, 34), 'text':'( Wang , et al. , 1994 ; You , et al. , 1993 ) .'}]}]}]}]}]}]}]}]}]}]}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(20, 0), 'end':(20, 4), 'text':'In brief , CSG :'}, {'label':'same-unit', 'direction':'None', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(20, 5), 'end':(20, 6), 'text':'an inflammation'}, {'start':(20, 7), 'end':(20, 14), 'text':'manifested by mild lymphocyte and plasma-cell infiltration ;'}]}, {'label':'attribution', 'direction':'RightToLeft', 'children':[{'start':(20, 15), 'end':(20, 16), 'text':'CAG :'}, {'label':'joint', 'direction':'None', 'children':[{'start':(20, 17), 'end':(20, 26), 'text':'glandular morphology disappeared partially or completely absent in the mucosa'}, {'label':'joint', 'direction':'None', 'children':[{'start':(20, 27), 'end':(20, 43), 'text':'and replaced by connective tissue , inter-glandular space was infiltrated mainly by plasma cells and lymphocytes ;'}, {'label':'same-unit', 'direction':'None', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(20, 44), 'end':(20, 45), 'text':'DYS :'}, {'start':(20, 46), 'end':(20, 63), 'text':'characterized by nuclear atypia with or without architectural abnormalities in the gastric epithelium , but without invasion ;'}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(20, 64), 'end':(20, 65), 'text':'IM :'}, {'start':(20, 66), 'end':(20, 76), 'text':'confirmed by the presence of goblet cells in gastric mucosa ;'}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(20, 77), 'end':(20, 81), 'text':'adenocarcinoma ( AC ) :'}, {'start':(20, 82), 'end':(20, 91), 'text':'invasion of neoplastic gastric cells through the basement membrane .'}]}]}]}]}]}]}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'joint', 'direction':'None', 'children':[{'start':(21, 0), 'end':(21, 1), 'text':'Immunohistochemical staining'}, {'label':'joint', 'direction':'None', 'children':[{'start':(22, 0), 'end':(22, 12), 'text':'Anti-p53 antibody is a monoclonal mouse anti-serum against p53 of human origin ,'}, {'start':(22, 13), 'end':(22, 30), 'text':'and recognizes both wild-type and mutant p53 ( Ab-6 , Oncogene Science , Manhasset , NY ) .'}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'joint', 'direction':'None', 'children':[{'start':(23, 0), 'end':(23, 30), 'text':'Anti-iNOS antibody is a monoclonal mouse anti-serum against the C-terminal domain of iNOS of human origin ( sc-7271 , Santa Cruz Biotechnology , Inc. , Santa Cruz , CA ) .'}, {'label':'joint', 'direction':'None', 'children':[{'start':(24, 0), 'end':(24, 11), 'text':'Anti-VEGF antibody is a polyclonal rabbit anti-serum against VEGF of human origin'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(24, 12), 'end':(24, 16), 'text':'and recognizes an amino-terminal epitope'}, {'start':(24, 17), 'end':(24, 37), 'text':'found in VEGF 121 , 165 , 189 and 206 ( Ab-2 , Oncogene Science , Manhasset , NY ) .'}]}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(25, 0), 'end':(25, 15), 'text':'The avidin-biotin-peroxidase complex method was used for the immunostaining of p53 , iNOS and VEGF .'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'background', 'direction':'LeftToRight', 'children':[{'start':(26, 0), 'end':(26, 2), 'text':'In brief ,'}, {'start':(26, 3), 'end':(26, 5), 'text':'after dewaxing ,'}]}, {'label':'joint', 'direction':'None', 'children':[{'start':(26, 6), 'end':(26, 9), 'text':'inactivating endogenous peroxidase activity'}, {'label':'joint', 'direction':'None', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(26, 10), 'end':(26, 15), 'text':'and blocking cross-reactivity with normal serum'}, {'start':(26, 16), 'end':(26, 27), 'text':'( Vectastain Elite Kit ; Vector , Burlingame , CA ) ,'}]}, {'label':'joint', 'direction':'None', 'children':[{'start':(26, 28), 'end':(26, 57), 'text':'the sections were incubated overnight at 4 * with a diluted solution of the primary antibodies ( 1:1000 for p53 , 1:200 for iNOS and 1:100 for VEGF ) .'}, {'label':'joint', 'direction':'None', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(27, 0), 'end':(27, 11), 'text':'Location of the primary antibodies was achieved by subsequent application of a'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(27, 12), 'end':(27, 20), 'text':'biotinylated anti-primary antibody , an avidin and biotin complex'}, {'start':(27, 21), 'end':(27, 39), 'text':'conjugated to horseradish peroxidase , and diaminobenzidine ( Vectastain Elite Kit , Vector , Burlingame , CA ) .'}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(28, 0), 'end':(28, 3), 'text':'The slides were counter'}, {'start':(28, 4), 'end':(28, 7), 'text':'stained by hematoxylin .'}]}]}, {'label':'manner-means', 'direction':'LeftToRight', 'children':[{'start':(29, 0), 'end':(29, 3), 'text':'Negative controls were established'}, {'start':(29, 4), 'end':(29, 17), 'text':'by replacing the primary antibody with PBS and normal mouse or rabbit serum .'}]}]}, {'start':(30, 0), 'end':(30, 9), 'text':'Known immunostaining positive slides were used as positive controls .'}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(31, 0), 'end':(31, 11), 'text':'Specific staining for each protein was categorized as either positive or negative'}, {'start':(31, 12), 'end':(31, 19), 'text':'based on the presence of brown-color staining .'}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(32, 0), 'end':(32, 4), 'text':'More than 10 % cells'}, {'start':(32, 5), 'end':(32, 11), 'text':'positively stained were graded as positive .'}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'same-unit', 'direction':'None', 'children':[{'start':(33, 0), 'end':(33, 16), 'text':'Clear staining for nuclei ( p53 ) , cytoplasm and cell membrane ( VEGF and iNOS )'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(33, 17), 'end':(33, 23), 'text':'was the criterion for a positive reaction'}, {'start':(33, 24), 'end':(33, 30), 'text':'( Wang et al. ,1994 ) .'}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(34, 0), 'end':(34, 18), 'text':'All the immunostaining slides were observed by two pathologists ( L D Wang and L H Jiao ) .'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'background', 'direction':'LeftToRight', 'children':[{'start':(35, 0), 'end':(35, 17), 'text':'The slides with different diagnosis by two pathologists were read again ( less than 5 % ) ,'}, {'start':(35, 18), 'end':(35, 24), 'text':'until the agreed diagnosis was made .'}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(36, 0), 'end':(36, 1), 'text':'Statistical Analysis'}, {'start':(37, 0), 'end':(37, 14), 'text':'The X 2 test was used for the percentage of samples with positive stain .'}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(38, 0), 'end':(38, 19), 'text':'Spearman correlation test and linear tendency test were used for the correlation between positive rates and different severities of lesions'}, {'start':(38, 20), 'end':(38, 28), 'text':'( p < 0.05 was considered significant ) .'}]}]}]}]}]}]}]}]}]}]}]}]}]}]}]}]}
123	125	{'label':'attribution', 'direction':'RightToLeft', 'children':[{'start':(0, 0), 'end':(0, 0), 'text':'Abbreviations'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(1, 0), 'end':(1, 4), 'text':'The abbreviations used are :'}, {'start':(1, 5), 'end':(1, 44), 'text':'CSG , chronic superficial gastritis ; CAG , chronic atrophic gastritis ; DYS , dysplasia ; GC , gastric adenocarcinoma ; iNOS , inducible nitric oxide synthase ; IM , intestinal metaplasia ; VEGF , vascular endothelial growth factor .'}]}]}
